Insider · CIK 0001431159
Tammenoms Bakker Juliet
Reports to the SEC for 21 companies · ALISO VIEJO, CA
Transactions
50
Companies
21
Filings
11
CIK
0001431159
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-17 | RXSTRxSight, Inc.A Award | — |
| 2026-06-02 | CBLLCeribell, Inc.A Award | — |
| 2025-06-10 | CBLLCeribell, Inc.A Award | — |
| 2025-06-03 | RXSTRxSight, Inc.A Award | — |
| 2024-10-15 | CBLLCeribell, Inc.C Conversion | — |
| 2024-10-15 | CBLLCeribell, Inc.P Purchase | +$4.03M |
| 2024-10-15 | CBLLCeribell, Inc. · Series C-1 Preferred StockC Conversion | — |
| 2024-10-11 | CBLLCeribell, Inc.A Award | — |
| 2024-06-06 | RXSTRxSight, Inc.A Award | — |
| 2024-05-17 | RXSTRxSight, Inc.P Purchase | +$305K |
| 2024-02-14 | RXSTRxSight, Inc.P Purchase | +$205K |
| 2024-02-12 | RXSTRxSight, Inc.P Purchase | +$202K |
| 2023-11-30 | RXSTRxSight, Inc.J Other | — |
| 2023-11-30 | RXSTRxSight, Inc.J Other | — |
| 2023-11-30 | RXSTRxSight, Inc.J Other | — |
| 2023-11-29 | RXSTRxSight, Inc.S Sale | −$10.4M |
| 2023-11-28 | RXSTRxSight, Inc.S Sale | −$4.3M |
| 2023-11-15 | RXSTRxSight, Inc.S Sale | −$10.9M |
| 2023-11-14 | RXSTRxSight, Inc.S Sale | −$2.71M |
| 2023-09-11 | RXSTRxSight, Inc.S Sale | −$88.5K |
| 2023-09-08 | RXSTRxSight, Inc.S Sale | −$303K |
| 2023-09-07 | RXSTRxSight, Inc.S Sale | −$601K |
| 2023-08-25 | RXSTRxSight, Inc.S Sale | −$474K |
| 2023-08-24 | RXSTRxSight, Inc.J Other | — |
| 2023-08-24 | RXSTRxSight, Inc.J Other | — |
| 2023-08-24 | RXSTRxSight, Inc.J Other | — |
| 2023-08-18 | RXSTRxSight, Inc.S Sale | −$426K |
| 2023-08-17 | RXSTRxSight, Inc.S Sale | −$556K |
| 2023-08-09 | RXSTRxSight, Inc.J Other | — |
| 2023-08-09 | RXSTRxSight, Inc.J Other | — |
| 2023-06-14 | RXSTRxSight, Inc.J Other | — |
| 2023-06-14 | RXSTRxSight, Inc.J Other | — |
| 2023-06-14 | RXSTRxSight, Inc.J Other | — |
| 2023-06-01 | RXSTRxSight, Inc.A Award | — |
| 2023-05-26 | RXSTRxSight, Inc.J Other | — |
| 2023-05-26 | RXSTRxSight, Inc.J Other | — |
| 2023-02-10 | RXSTRxSight, Inc.P Purchase | +$6M |
| 2022-06-02 | RXSTRxSight, Inc.A Award | — |
| 2021-08-03 | RXSTRxSight, Inc.P Purchase | +$200K |
| 2021-08-03 | RXSTRxSight, Inc.C Conversion | — |
| 2021-08-03 | RXSTRxSight, Inc.P Purchase | +$2M |
| 2021-08-03 | RXSTRxSight, Inc.P Purchase | +$8M |
| 2021-08-03 | RXSTRxSight, Inc. · Series G Preferred StockC Conversion | — |
| 2021-08-03 | RXSTRxSight, Inc. · Series H Preferred StockC Conversion | — |
| 2021-08-03 | RXSTRxSight, Inc. · Warrant (right to buy)M Exercise/Conversion | — |
| 2021-08-03 | RXSTRxSight, Inc. · Series H Preferred StockM Exercise/Conversion | — |
| 2021-08-03 | RXSTRxSight, Inc. · Series H Preferred StockF Tax Payment | — |
| 2021-08-03 | RXSTRxSight, Inc. · Series H Preferred StockC Conversion | — |
| 2021-07-30 | RXSTRxSight, Inc.A Award | — |
| 2021-05-17 | Eargo, Inc.J Other | — |
Recent filings
- 4Tammenoms Bakker Juliet0001193125-26-275823SEC(opens sec.gov)
- 4Tammenoms Bakker Juliet0001193125-26-257823SEC(opens sec.gov)
- 4Tammenoms Bakker Juliet0000950170-25-087602SEC(opens sec.gov)
- 4Tammenoms Bakker Juliet0000950170-25-081955SEC(opens sec.gov)
- 4Tammenoms Bakker Juliet0000950170-24-115007SEC(opens sec.gov)
- 4Tammenoms Bakker Juliet0000950170-24-071288SEC(opens sec.gov)
- 4Tammenoms Bakker Juliet0000950170-24-062883SEC(opens sec.gov)
- 4Tammenoms Bakker Juliet0000950170-24-015900SEC(opens sec.gov)
- 4Tammenoms Bakker Juliet0000950170-23-067110SEC(opens sec.gov)
- 4Tammenoms Bakker Juliet0000950170-23-064616SEC(opens sec.gov)
- 4Tammenoms Bakker Juliet0000950170-23-047537SEC(opens sec.gov)
Companies
- 89bio, Inc.10% OwnerETNB
- Aimmune Therapeutics, Inc.10% Owner
- Aptinyx Inc.10% Owner
- Axonics, Inc.Director
- Ceribell, Inc.DirectorCBLL
- COLLEGIUM PHARMACEUTICAL, INC10% OwnerCOLL
- CORCEPT THERAPEUTICS INC10% OwnerCORT
- Eargo, Inc.Director, 10% Owner
- Esperion Therapeutics, Inc.10% OwnerESPR
- Inozyme Pharma, Inc.10% Owner
- KALA BIO, Inc.10% OwnerKALA
- Lexeo Therapeutics, Inc.10% OwnerLXEO
- Molecular Templates, Inc.10% Owner
- RAPID MICRO BIOSYSTEMS, INC.10% OwnerRPID
- RxSight, Inc.DirectorRXST
- Sierra Oncology, Inc.10% Owner
- Tourmaline Bio, Inc.10% OwnerTRML
- Tricida, Inc.10% Owner
- Vaxcyte, Inc.10% OwnerPCVX
- Venus Concept Inc.Former DirectorVERO
- Vera Therapeutics, Inc.10% OwnerVERA
Address
C/O RXSIGHT, INC. 100 COLUMBIA
ALISO VIEJO, CA, 92656